Clinical trial using dorsaVi sensors demonstrates significant reduction in back pain

New data from a cluster randomised controlled trial has demonstrated that back pain patients monitored and treated using wearable movement sensors from dorsaVi Ltd (ASX:DVL) had a significant and…